mPEG-PLA from PolySciTech used in development of simvastatin delivery system to treat neuroinflammation.

Inflammation is a natural response to injury or infection which can also lead to significant health problems. Recently, researchers at Kent State University used mPEG-PLA (AK021) from PolySciTech (www.polyscitech.com) to create nanoparticles for intraceullular delivery of anti-inflammatory agents. This research holds promise to treate a variety of inflammatory-related disease states. Read more: Manickavasagam, Dharani, and Moses O. Oyewumi. "Internalization of particulate delivery systems by activated microglia influenced the therapeutic efficacy of simvastatin repurposing for neuroinflammation." International Journal of Pharmaceutics 570 (2019): 118690. https://www.sciencedirect.com/science/article/pii/S0378517319307355

“Abstract: We recently evaluated the suitability of polymersome delivery systems in simvastatin repurposing for treating neuroinflammation. The goal of the current study is to elucidate the therapeutic impact of particulate internalization by activated microglia on the resultant anti-inflammatory properties. Thus, we investigated the endocytic mechanism(s) involved in uptake and transport of simvastatin-loaded polymersomes by BV2 microglia cells coupled with delineation of the intracellular pathway(s) involved in regulating anti-inflammatory effects. Our data indicated that internalization of polymersome delivery systems by activated microglial BV2 cells was important in the suppression of nitric oxide (NO), TNF-α and IL-6 production. Further, we observed that the lipid raft/caveolae pathway had the most influential effect on polymersome internalization by microglia cells while clathrin-mediated endocytosis did not play a major role. Enhancement of anti-inflammatory effects of simvastatin could be attributed to inhibition of ERK1/2, JNK and AKT signaling pathways and internalization of polymersome delivery systems in activated microglia. Taken together, our data provided insights into how the intracellular trafficking of delivery systems by microglial could be a useful tool in modulating the desired anti-inflammatory effects of drugs.”

--> Save-the-date: Akina, Inc's third annual Biotech-Pharma-Cancer-Research (BPCR) conference is August 26 at Kurz Purdue Technology Center (KPTC) (http://bpcrconference.com/).